OWEN OSAGIE: Open Payments
NPI 1164534426 · ROSENBERG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,281 in 98 payments from 9 companies in 2025. Trend: 2023 $1,207 · 2024 $1,241 · 2025 $2,281
Food & beverage: $2,067Education: $214
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 29 | $907 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $356 |
| Otsuka America Pharmaceutical, Inc. | 14 | $323 |
| Neurocrine BioSciences, Inc. | 14 | $291 |
| E.R. Squibb & Sons, L.L.C. | 14 | $199 |
| Janssen Pharmaceuticals, Inc | 9 | $139 |
| Vanda Pharmaceuticals Inc. | 2 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: UZEDY, CAPLYTA, AUSTEDO XR, INGREZZA, COBENFY, ABILIFY MAINTENA, INVEGA SUSTENNA, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
